The Significance of Eosinophil-to-Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series

Omalizumab, a monoclonal anti-IgE antibody, has been used off-label in a few case series of bullous pemphigoids (BPs) with rapid efficacy and high safety profile. However, there is a lack of data to select patients who would get the most therapeutic benefit from omalizumab therapy. To assess if eosi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Indian journal of dermatology 2024-01, Vol.69 (1), p.81-85
Hauptverfasser:	Akin, Gülfem, Avci, Ceylan, Akarsu, Sevgi
Format:	Artikel
Sprache:	eng
Schlagworte:	Bullous pemphigoid Case Report Health aspects Immunoglobulin E Lymphocytes Medical records Medical research Medicine, Experimental Monoclonal antibodies Omalizumab
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!